Research News and Research

RSS

LIVALO statin effective than simvastatin in reducing lipid levels

New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol

22 Oct 2009

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

Accredo Health Group Inc. announced a 10-year renewal of its 240,000-square-foot headquarters at Century Center, positioning the nation's largest specialty pharmacy and a major fixture of Memphis' health care industry for future growth. The General Investment & Development Companies and Accredo agreed to renew all leases for Accredo's five-building campus, effective January 1, 2010.

22 Oct 2009

BioCube completes initial phase development of environmentally safe decontamination system

Spring Creek Capital Corporation (OTCBB: SCRK), a Nevada corporation, announced today that one of its portfolio companies, BioCube, Inc., has completed the initial phase of the development of an environmentally safe decontamination system, utilizing an aerosol-based delivery method of aqueous solution.

22 Oct 2009

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

Applied Biosystems, part of Life Technologies Corporation, today announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems’ industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for throughput, data quality and ease of use.

22 Oct 2009

Smith & Nephew to present comprehensive portfolio of advanced wound management products at Annual Clinical Symposium

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), announced today that clinicians will present a total of 20 clinical posters featuring its Negative Pressure Wound Therapy (NPWT) Systems and ALLEVYN(TM) AG, ALLEVYN AG Gentle, ACTICOAT(TM) and IODOSORB(TM) advanced wound dressings during the 24th Annual Clinical Symposium on Advances in Skin and Wound Care's poster session. The poster session opens at 10:30am CT on October 23, 2009.

22 Oct 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb Company today reported strong sales and earnings growth for the third quarter 2009.

22 Oct 2009

Celgene announces fiscal 2009 third-quarter results

Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $259.8 million, or non-GAAP earnings per diluted share of $0.56 for the quarter ended September 30, 2009. Non-GAAP net income for the third quarter of 2008 was $185.9 million, or non-GAAP earnings per diluted share of $0.40.

22 Oct 2009

NCI implements NanoString Technologies' nCounter Analysis System

NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that the National Cancer Institute (NCI) is employing its nCounter™ Analysis System at two of its core labs.

From NanoString Technologies 22 Oct 2009

Amorfix Life Sciences signs sale and distribution agreement with Cedarlane Laboratories

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, announced today that it has signed an agreement with Cedarlane Laboratories for the sale and distribution of Amorfix's proprietary antibodies and reagents.

22 Oct 2009

Cold laser relieves pain and accelerates healing of muscle injuries

Acupuncture is widely acclaimed for relieving pain. However, many people would rather endure the crushing pain of migraine headaches than face their fear of needles. Nicholas C. Steadman, L.Ac., who practices acupuncture in New York City, claims to have erased that barrier with the use of cold laser acupuncture.

22 Oct 2009

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter ended September 30, 2009.

22 Oct 2009

Schering-Plough announces 2009 third quarter financial results

Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2009 third quarter.

22 Oct 2009

First Edition: October 22, 2009

Some clear themes emerge from today's headlines. Among them: A new government report indicates that health costs grow even faster under Democratic legislation pending in the House; and, yesterday's Senate vote to block the Medicare pay fix bill represents an important loss for Majority Leader Harry Reid.

22 Oct 2009

FPB awarded $3.7M in six stimulus grants

The Frances Payne Bolton School of Nursing (FPB) at Case Western Reserve University was recently awarded $3.7 million in six stimulus grants from various federal offices to fund innovative research and academic programs.

22 Oct 2009

PAREXEL to present key trends in late phase development and Comparative Effectiveness Research

Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will address key trends in late phase development and Comparative Effectiveness Research at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 12th Annual European Congress, to be held from October 24 - 27, 2009 in Paris, France.

From Parexel 22 Oct 2009

Thermo Fisher Scientific's revenues decrease by 2% in third quarter 2009

Thermo Fisher Scientific Inc., the world leader in serving science, reported that revenues decreased 2% to $2.53 billion in the third quarter of 2009, compared with $2.59 billion in the 2008 quarter. These results reflect the impact of foreign currency translation, which lowered revenues by 2%, and acquisitions, which increased revenues by 2%. GAAP diluted earnings per share (EPS) were $.53 in 2009, versus $.50 in the year-ago period. GAAP operating income for the 2009 quarter was $275 million, compared with $286 million in 2008, and GAAP operating margin was 10.9%, compared with 11.1% a year ago.

From Thermo Fisher Scientific Inc. 22 Oct 2009

First clinical trial to test a weight maintenance program for obese pregnant women

More than half of women in the United States are overweight or obese when they become pregnant, and most go on to gain more than the recommended amount during pregnancy. The excess weight can lead to a myriad of complications, including preeclampsia, diabetes, bigger babies, C-sections, birth injuries, and weight retention after pregnancy.

22 Oct 2009

Pilot study examines the concordance of Quotient ADHD Test

BioBehavioral Diagnostics Company announced today that their poster has been accepted through a rigorous peer-review process for inclusion as a New Research Poster presentation at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP) in Honolulu, HI, October 27-November 1, 2009.

22 Oct 2009

More infants are being immunized but funding gap leaves millions of children still at risk

Reversing a downward trend, immunization rates are now at their highest ever and vaccine development worldwide is booming, according to a new assessment released today by the World Health Organization (WHO), UNICEF and the World Bank.

22 Oct 2009

The Melting Pot Restaurants' initiative for cancer research

The Melting Pot Restaurants join St. Jude Children’s Research Hospital in the sixth annual Thanks and Giving campaign from Oct. 31 – Dec. 5 to “give thanks for the healthy kids in your life, and give to those who are not” by donating a portion of proceeds to cancer research.

22 Oct 2009

Research News and Research

LIVALO statin effective than simvastatin in reducing lipid levels

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

BioCube completes initial phase development of environmentally safe decontamination system

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

Smith & Nephew to present comprehensive portfolio of advanced wound management products at Annual Clinical Symposium

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Celgene announces fiscal 2009 third-quarter results

NCI implements NanoString Technologies' nCounter Analysis System

Amorfix Life Sciences signs sale and distribution agreement with Cedarlane Laboratories

Cold laser relieves pain and accelerates healing of muscle injuries

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Schering-Plough announces 2009 third quarter financial results

First Edition: October 22, 2009

FPB awarded $3.7M in six stimulus grants

PAREXEL to present key trends in late phase development and Comparative Effectiveness Research

Thermo Fisher Scientific's revenues decrease by 2% in third quarter 2009

First clinical trial to test a weight maintenance program for obese pregnant women

Pilot study examines the concordance of Quotient ADHD Test

More infants are being immunized but funding gap leaves millions of children still at risk

The Melting Pot Restaurants' initiative for cancer research

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms